| NAME OF THE PROJECT | : Ranitidine Hydrochloride |
| PRODUCT NAME | : Ranitidine Impurity |
| CODE & CAT NO | : LP - 4790-03-010 |
| MOLECULAR FORMULA | : C13H21N3O3S2 |
| MOLECULAR WEIGHT | : 331.45 |
| CAS NO | : 72115-14-1 |
| CHEMICAL NAME | :1[2-(5-Dimethylaminomethyl)-2-furanyl)methylthio]ethylamino]-1-methylthio-2-nitroethane |
| CAT NO | : LP - 4790-01-001 |
| CAS NO | : 66357-59-3 |
| Mol.F | :C13H22N4O3S,HCl |
| Mol.Wt. | : 350.9 |
| CAT NO | : LP - 4790-03-001 |
| CAS NO | : 72126-78-4 |
| Mol.F | : C22H35N5O4S2 |
| Mol.Wt. | : 497.67 |
| CAT NO | : LP - 4790-03-002 |
| CAS NO | : 66356-53-4 |
| Mol.F | : C10H18N2OS |
| Mol.Wt. | : 214.33 |
| CAT NO | : LP - 4790-03-003 |
| CAS NO | : 73851-70-4 |
| Mol.F | : C13H22N4O4S |
| Mol.Wt. | : 330.41 |
| CAT NO | : LP - 4790-03-004 |
| CAS NO | : 112251-56-6 |
| Mol.F | : C12H19N3O4S |
| Mol.Wt. | : 301.36 |
| CAT NO | : LP - 4790-03-005 |
| CAS NO | : 73857-20-2 |
| Mol.F | : C12H20N4O4S |
| Mol.Wt. | : 316.38 |
| CAT NO | : LP - 4790-03-006 |
| CAS NO | : 81074-81-9 |
| Mol.F | : C8H13NO2 |
| Mol.Wt. | : 155.19 |
| CAT NO | : LP - 4790-03-007 |
| CAS NO | : 112233-23-5 |
| Mol.F | : C5H9N3OS |
| Mol.Wt. | : 159.21 |
| CAT NO | : LP - 4790-03-008 |
| CAS NO | : 72078-82-1 |
| Mol.F | : C3H6N2O3 |
| Mol.Wt. | : 118.09 |
| CAT NO | : LP - 4790-03-009 |
| CAS NO | : 61832-41-5 |
| Mol.F | : C4H8N2O2S |
| Mol.Wt. | : 148.18 |
| CAT NO | : LP-4790-03-013 |
| CAS NO | : 91224-69-0 |
| Mol.F | : C24H40N4O6S2 |
| Mol.Wt. | : 544.73 |
| CAT NO | : LP-4790-03-001 |
| CAS NO | : 72126-78-4 |
| Mol.F | : C22H35N5O4S2 |
| Mol.Wt. | : 497.67 |
| CAT NO | : LP-4790-03-003 |
| CAS NO | : 73851-70-4 |
| Mol.F | : C13H23N4O4S |
| Mol.Wt. | : 331.41 |
| CAT NO | : LP - 4790-03-010 |
| CAS NO | : 72115-14-1 |
| Mol.F | : C13H21N3O3S2 |
| Mol.Wt. | : 331.45 |
| CAT NO | : LP - 4790-03-011 |
| CAS NO | : 73851-70-4 |
| Mol.F | : C4H9N3O2 |
| Mol.Wt. | : 131.13 |
CATEGORY : Ranitidine Hydrochloride
TOTAL PRODUCTS : 15
FILTER BY : API
Lavybens pharma's competitive advanced manufacturing facilities, R & D capabilities, extensive domestic network in Indian Pharma market and International.
Copyrights © Lavybens Pharma All rights Reserved
